- Elon Musk's venture, Neuralink, a pioneering force in brain implantation endeavors, has successfully secured an infusion of $280 million in fresh funding from a consortium of investors, fortifying its commitment to advancing technologies. The announcement of this funding initiative was disseminated through a post on X, formerly known as Twitter.
- The driving force behind this funding drive was the Founders Fund, a venture capital entity with the backing of billionaire Peter Thiel. Neuralink's preeminent stature in the burgeoning landscape of brain technology development has not only garnered significant attention but has also catalyzed investor confidence in numerous startups exploring akin technologies.
Why it matters
Neuralink recently received approval from the US Food and Drug Administration to conduct human clinical trials. The company is developing a small device that uses wires with electrodes to connect the brain to a computer. Earlier this year, the US Department of Transportation launched an investigation into the company after an animal advocacy group said it had obtained emails indicating that the startup did not follow proper procedures when shipping suspected hazardous materials.